샘플 요청 목록

 카트 문의
시장보고서
상품코드
1650919

세계의 생체흡수성(재흡수성) 폴리머 시장

Bioresorbable (Resorbable) Polymers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생체흡수성(재흡수성) 폴리머 시장은 2030년까지 28억 달러에 달할 전망

2024년에 17억 달러로 추정되는 세계의 생체흡수성(재흡수성) 폴리머 시장은 2024-2030년에 CAGR 8.7%로 성장하며, 2030년에는 28억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 폴리유산(PLA)은 CAGR 8.9%를 기록하며, 분석 기간 종료시에는 11억 달러에 달할 것으로 예상됩니다. 폴리글리콜산(PGA) 부문의 성장률은 분석 기간에 CAGR 7.3%로 추정됩니다.

미국 시장은 4억 7,500만 달러로 추정, 중국은 CAGR 8.0%로 성장 예측

미국의 생체흡수성(재흡수성) 폴리머 시장은 2024년에 4억 7,500만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 8.0%로 추이하며, 2030년에는 4억 2,340만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 8.0%와 7.0%로 예측됩니다. 유럽에서는 독일이 CAGR 약 7.0%로 성장할 것으로 예측됩니다.

세계의 생체흡수성(재흡수성) 폴리머 시장 - 주요 동향과 촉진요인 정리

생체흡수성 폴리머란?

재흡수성 고분자 또는 생분해성 고분자라고도 알려진 생체흡수성 고분자는 의료 분야에 혁명을 일으켜 목적을 달성한 후 안전하게 분해되어 체내로 흡수되는 물질을 제공합니다. 이러한 폴리머는 가수분해, 효소 작용 및 기타 생물학적 과정을 통해 자연적으로 분해되도록 설계되었습니다. 생체흡수성 폴리머의 가장 큰 장점은 임플란트 제거를 위한 재수술이 필요하지 않다는 점이며, 봉합사, 약물전달 시스템, 정형외과용 임플란트 등의 용도에서 매우 유용하게 사용될 수 있다는 점입니다. 그 용도는 의료 분야에만 국한되지 않고, 환경 친화적인 성질을 활용하여 생분해성 포장 등 환경 분야로의 적용도 검토되고 있습니다. 이러한 폴리머의 다용도성과 생체적합성은 의료기술과 지속가능한 실천을 발전시키는 데 있으며, 중요한 컴포넌트로 자리매김하고 있습니다.

기술 발전은 생체흡수성 고분자 시장을 어떻게 형성하고 있는가?

생체흡수성 고분자 시장은 이러한 재료의 특성과 용도를 향상시키는 지속적인 기술 발전으로 인해 크게 성장하고 있습니다. 연구개발은 다양한 의료 용도의 특정 요구를 충족시키기 위해 이러한 폴리머의 기계적 강도, 분해 속도 및 생체 적합성을 향상시키는 데 초점을 맞추었습니다. 예를 들어 새로운 공중합체 배합은 하중을 지탱하는 정형외과용 임플란트에 필수적인 유연성과 강도를 모두 갖춘 재료를 만들기 위해 개발되고 있습니다. 또한 생체흡수성 폴리머를 이용한 약물전달 시스템의 발전으로 치료제를 보다 제어되고 지속적으로 방출할 수 있게 되어 치료 효과가 향상되고 있으며, 3D 프린팅 기술과 생체흡수성 폴리머의 결합은 맞춤형 의료의 새로운 길을 열어 개별 환자의 필요에 따라 맞춤형 임플란트 및 비계 제작을 가능하게 하고 있습니다. 이러한 기술의 발전은 생체흡수성 폴리머의 용도를 넓힐 뿐만 아니라 중요한 의료 시술의 성능을 향상시키는 데에도 기여하고 있습니다.

최종사용자 동향은 생체흡수성 폴리머의 채택에 어떤 역할을 하는가?

생체흡수성 폴리머의 채택은 최종 사용 산업, 특히 헬스케어 분야의 동향 변화와 밀접한 관련이 있습니다. 전 세계에서 고령화가 진행됨에 따라 합병증 발생률을 낮추고 회복 시간을 단축할 수 있는 첨단 의료기기 및 임플란트에 대한 수요가 증가하고 있습니다. 이러한 수요로 인해 정형외과, 심장학, 약물전달 시스템에서 생체흡수성 재료의 채택이 증가하고 있습니다. 또한 만성질환의 유병률 증가와 최소 침습 수술에 대한 관심은 생체흡수성 폴리머의 사용을 촉진하고 있습니다. 이러한 재료는 덜 침습적이고 재수술의 필요성을 줄여주는 기구의 개발을 지원하고 있기 때문입니다. 헬스케어뿐만 아니라 환경 분야에서도 기존 플라스틱을 대체할 수 있는 지속가능한 소재를 찾기 위해 생흡수성 폴리머에 대한 관심이 높아지고 있습니다. 이러한 추세는 특히 포장 산업에서 두드러지게 나타나고 있으며, 친환경 제품을 원하는 소비자의 요구에 따라 생분해성 소재가 인기를 끌고 있습니다. 이러한 동향이 여러 분야에 걸쳐 수렴되면서 생흡수성 고분자 시장이 크게 성장하고 있습니다.

생체흡수성 고분자 시장의 성장을 가속하는 요인은 무엇인가?

생체흡수성 고분자 시장의 성장을 가속하는 몇 가지 요인이 있으며, 각 요인은 이러한 혁신적인 재료에 대한 수요 증가에 중요한 역할을 합니다. 고분자 과학의 지속적인 개선으로 생체흡수성 재료의 성능, 신뢰성 및 적용 범위가 향상됨에 따라 기술 발전이 최전선에 있습니다. 의료 분야에서는 스텐트, 나사, 봉합사 등의 기구에서 생체적합성과 재흡수성을 갖춘 재료에 대한 요구가 증가하고 있으며, 저침습적 수술에 대한 선호도가 높아지면서 이를 지원하고 있습니다. 소비자와 산업계 모두 기존 플라스틱을 대체할 수 있는 친환경 소재를 찾고 있으며, 지속가능성을 추구하는 움직임도 큰 요인으로 작용하고 있습니다. 특히 헬스케어 및 환경 분야에서 생분해성 소재에 대한 규제적 지원은 시장 성장을 더욱 촉진하고 있습니다. 또한 공공 및 민간 부문의 R&D 투자 증가는 새로운 생흡수성 폴리머의 개발을 가속화하고 상업적 활용 가능성을 확대하고 있습니다. 이러한 요인들이 결합하여 생체흡수성 고분자 시장은 탄탄한 성장 환경을 조성하고 있으며, 헬스케어 및 지속가능한 소재 분야에서 미래의 중요한 기업으로 자리매김하고 있습니다.

부문

유형(폴리유산(PLA), 폴리글리콜산(PGA), 폴리유산-공글리콜산(PLGA), 폴리카프로락톤(PCL), 기타 유형, 용도(정형외과, 약물전달, 기타 용도))

조사 대상 기업의 예(주목 11사)

  • Advanced Extrusion, Inc.
  • Corbion NV
  • Foster Corporation
  • JSP Corporation.
  • MAST Biosurgery AG
  • Poly-Med, Inc.
  • R3 Vascular Inc.
  • REVA Medical, Inc.
  • Shandong ThFine Chemical Co., Ltd.
  • Teknimed

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.02.25

Global Bioresorbable (Resorbable) Polymers Market to Reach US$2.8 Billion by 2030

The global market for Bioresorbable (Resorbable) Polymers estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Polylactic Acid (PLA), one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Polyglycolic Acid (PGA) segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$475.0 Million While China is Forecast to Grow at 8.0% CAGR

The Bioresorbable (Resorbable) Polymers market in the U.S. is estimated at US$475.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$423.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.0% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Bioresorbable (Resorbable) Polymers Market - Key Trends and Drivers Summarized

What Are Bioresorbable Polymers?

Bioresorbable polymers, also known as resorbable or biodegradable polymers, have revolutionized the medical field, offering materials that can safely break down and be absorbed by the body after fulfilling their purpose. These polymers are engineered to degrade naturally through hydrolysis, enzymatic action, or other biological processes. The key advantage of bioresorbable polymers is their ability to eliminate the need for a second surgery to remove implants, making them highly beneficial in applications like sutures, drug delivery systems, and orthopedic implants. Their use is not limited to the medical field; these materials are also being explored in environmental applications, such as biodegradable packaging, due to their eco-friendly nature. The versatility and biocompatibility of these polymers have positioned them as crucial components in advancing both medical technology and sustainable practices.

How Are Technological Advances Shaping the Bioresorbable Polymers Market?

The bioresorbable polymers market has seen significant growth thanks to continuous technological advancements that enhance the properties and applications of these materials. Research and development efforts are focused on improving the mechanical strength, degradation rates, and biocompatibility of these polymers to meet the specific needs of various medical applications. For instance, new copolymer formulations are being developed to create materials that offer both flexibility and strength, which are essential in load-bearing orthopedic implants. Moreover, advancements in drug delivery systems using bioresorbable polymers have allowed for more controlled and sustained release of therapeutic agents, improving treatment efficacy. The integration of 3D printing technology with bioresorbable polymers has opened new avenues for personalized medicine, enabling the creation of custom-made implants and scaffolds tailored to individual patient needs. These technological strides are not only expanding the applications of bioresorbable polymers but also enhancing their performance in critical medical procedures.

What Role Do End-Use Trends Play in the Adoption of Bioresorbable Polymers?

The adoption of bioresorbable polymers is closely tied to shifting trends in end-use industries, particularly healthcare. As the global population ages, there is a growing demand for advanced medical devices and implants that offer reduced complication rates and faster recovery times. This demand has led to increased adoption of bioresorbable materials in orthopedics, cardiology, and drug delivery systems. Additionally, the rising incidence of chronic diseases and the emphasis on minimally invasive procedures are driving the use of bioresorbable polymers, as these materials support the development of devices that are less invasive and reduce the need for repeat surgeries. Beyond healthcare, there is also a growing interest in bioresorbable polymers within the environmental sector, as industries seek sustainable alternatives to traditional plastics. This trend is particularly evident in the packaging industry, where biodegradable materials are becoming more popular due to consumer demand for eco-friendly products. The convergence of these trends across multiple sectors is significantly boosting the market for bioresorbable polymers.

What’s Fueling the Growth of the Bioresorbable Polymers Market?

The growth in the bioresorbable polymers market is driven by several factors, each playing a crucial role in expanding the demand for these innovative materials. Technological advancements are at the forefront, as continuous improvements in polymer science enhance the performance, reliability, and application range of bioresorbable materials. In the medical sector, the rising need for biocompatible and resorbable materials in devices such as stents, screws, and sutures is a major driver, fueled by the increasing preference for minimally invasive surgical procedures. The push towards sustainability is another significant factor, as both consumers and industries seek environmentally friendly alternatives to conventional plastics. Regulatory support for biodegradable materials, particularly in the healthcare and environmental sectors, is further propelling market growth. Additionally, the increasing R&D investments from both public and private sectors are accelerating the development of new bioresorbable polymers, thereby expanding their commercial viability. Together, these factors are creating a robust growth environment for the bioresorbable polymers market, positioning it as a key player in the future of both healthcare and sustainable materials.

SCOPE OF STUDY:

The report analyzes the Bioresorbable (Resorbable) Polymers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL), Other Types); Application (Orthopedics, Drug Delivery, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Advanced Extrusion, Inc.
  • Corbion NV
  • Foster Corporation
  • JSP Corporation.
  • MAST Biosurgery AG
  • Poly-Med, Inc.
  • R3 Vascular Inc.
  • REVA Medical, Inc.
  • Shandong ThFine Chemical Co., Ltd.
  • Teknimed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bioresorbable (Resorbable) Polymers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biodegradable Medical Devices Spurs Growth of Bioresorbable Polymers Market
    • Advancements in Polymer Engineering Expand Addressable Market Opportunity for Bioresorbable Solutions
    • Increased Focus on Sustainability Strengthens Business Case for Bioresorbable Polymers
    • Growing Application of Bioresorbable Polymers in Orthopedic Implants Drives Market Penetration
    • Shifts Towards Minimally Invasive Surgeries Generates Demand for Resorbable Polymer-Based Products
    • Emerging Innovations in Drug Delivery Systems Boost Market for Bioresorbable Polymers
    • Increased Patient Preference for Non-Permanent Implants Throws the Spotlight on Bioresorbable Polymers
    • Expanding Use of Bioresorbable Polymers in Tissue Engineering Sustains Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Polylactic Acid (PLA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Polylactic Acid (PLA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Polylactic Acid (PLA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Polyglycolic Acid (PGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Polyglycolic Acid (PGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Polyglycolic Acid (PGA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Poly (Lactic-Co-Glycolic Acid) (PLGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Poly (Lactic-Co-Glycolic Acid) (PLGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Poly (Lactic-Co-Glycolic Acid) (PLGA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Polycaprolactone (PCL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Polycaprolactone (PCL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Polycaprolactone (PCL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Bioresorbable (Resorbable) Polymers Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bioresorbable (Resorbable) Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Bioresorbable (Resorbable) Polymers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bioresorbable (Resorbable) Polymers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Bioresorbable (Resorbable) Polymers by Application - Orthopedics, Drug Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Application - Percentage Breakdown of Value Sales for Orthopedics, Drug Delivery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Bioresorbable (Resorbable) Polymers by Type - Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Bioresorbable (Resorbable) Polymers by Type - Percentage Breakdown of Value Sales for Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL) and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제